Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.75 |
| ▸ | MAPT | P10636 | 2/20 | 0.75 |
| ▸ | HTT | P42858 | 2/20 | 0.75 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.75 |
| ▸ | LMNA | P02545 | 2/20 | 0.75 |
| ▸ | USP2 | O75604 | 1/20 | 0.75 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.75 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.70 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.51 |
| ▸ | FTO | Q9C0B1 | 8/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | RECQL | P46063 | 1/20 | 0.45 |
| ▸ | BLM | P54132 | 1/20 | 0.45 |
| ▸ | SMAD3 | P84022 | 1/20 | 0.45 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.45 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29663660 | 1.00 | MEN1 (0.75) | MEN1MAPTHTTKMT2ALMNA | |
| SCHEMBL6663204 | 1.00 | MEN1 (0.75) | MEN1MAPTHTTKMT2ALMNA | |
| SCHEMBL30224109 | 0.96 | MEN1 (0.72) | MEN1MAPTHTTKMT2ALMNA | |
| SCHEMBL16994104 | 0.95 | LMNA (0.68) | MEN1MAPTHTTKMT2ALMNA | |
| SCHEMBL29349471 | 0.92 | MEN1 (0.73) | MEN1MAPTHTTKMT2ALMNA | |
| SCHEMBL30112719 | 0.92 | MEN1 (0.73) | MEN1MAPTHTTKMT2ALMNA | |
| SCHEMBL5277430 | 0.92 | MEN1 (0.73) | MEN1MAPTHTTKMT2ALMNA | |
| SCHEMBL18677730 | 0.92 | MAPT (0.77) | MEN1MAPTHTTKMT2ALMNA | |
| SCHEMBL13237867 | 0.88 | MEN1 (0.58) | MEN1MAPTHTTKMT2ALMNA | |
| SCHEMBL30298937 | 0.88 | MEN1 (0.58) | MEN1MAPTHTTKMT2ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122070479-A | Ultrasonic indicating device and method for monitoring ultrasonic treatment | JP实验室股份有限公司 | 2026-05-19 | — | — | CN | claimed |
| EP-4409261-B1 | METHOD FOR DETECTING, QUANTIFYING AND CHARACTERISING BRETTANOMYCES SPP. AND OTHER YEASTS CONTAINED IN AN ORGANIC LIQUID SUBSTRATE CONTAINING FERMENTABLE SUGARS | MD INVENT OENO (FR) | 2026-02-11 | — | — | EP | claimed |
| US-20250172486-A1 | METHOD FOR DETECTING, QUANTIFYING AND CHARACTERIZING BRETTANOMYCES SPP YEASTS AND OTHER YEASTS CONTAINED IN AN ORGANIC LIQUID SUBSTRATE CONTAINING FERMENTABLE SUGARS | MD INVENTION OENO (FR) | 2025-05-29 | — | — | US | claimed |
| WO-2025090061-A1 | ULTRASONIC INDICATOR DEVICE AND METHOD FOR MONITORING ULTRASONICATION | JP LABORATORIES, INC. (US) | 2025-05-01 | — | — | WO | claimed |
| WO-2025075611-A1 | ULTRASONIC INDICATOR BASED ON EMULSION FORMATION | JP LABORATORIES, INC. (US) | 2025-04-10 | — | — | WO | claimed |
| US-20240393229-A1 | METHOD FOR DETECTING AND QUANTIFYING FUNGI AND BACTERIA USING FLOW CYTOMETRY | MD INVENTION AGRO (FR) | 2024-11-28 | — | — | US | claimed |
| EP-4409261-A1 | METHOD FOR DETECTING, QUANTIFYING AND CHARACTERISING BRETTANOMYCES SPP. AND OTHER YEASTS CONTAINED IN AN ORGANIC LIQUID SUBSTRATE CONTAINING FERMENTABLE SUGARS | MD Invention Oeno (FR) | 2024-08-07 | — | — | EP | claimed |
| EP-4409262-A1 | METHOD FOR DETECTING AND QUANTIFYING FUNGI AND BACTERIA USING FLOW CYTOMETRY | MD Invention Agro (FR) | 2024-08-07 | — | — | EP | claimed |
| CN-118169090-A | Evaluation method and application of yeast wine-producing activity in fermented grains | 贵州茅台酒股份有限公司 | 2024-06-11 | — | — | CN | claimed |
| WO-2023053004-A1 | METHOD FOR DETECTING AND QUANTIFYING FUNGI AND BACTERIA USING FLOW CYTOMETRY | MD INVENTION AGRO (FR) | 2023-04-06 | — | — | WO | claimed |
| WO-2023053002-A1 | METHOD FOR DETECTING, QUANTIFYING AND CHARACTERISING BRETTANOMYCES SPP. AND OTHER YEASTS CONTAINED IN AN ORGANIC LIQUID SUBSTRATE CONTAINING FERMENTABLE SUGARS | MD INVENTION OENO (FR) | 2023-04-06 | — | — | WO | claimed |
| CN-122070479-A | Ultrasonic indicating device and method for monitoring ultrasonic treatment | JP实验室股份有限公司 | 2026-05-19 | — | — | CN | disclosed |
| CN-122030444-A | Method for prolonging normal-temperature shelf life of fermented flour product | 中国农业科学院农产品加工研究所 | 2026-05-15 | — | — | CN | disclosed |
| US-12622975-B2 | Peptide-conjugated prodrugs | BRANDEIS UNIVERSITY (US) | 2026-05-12 | — | — | US | disclosed |
| US-20260124140-A1 | NON-FOULING OR SUPER STEALTH VESICLE | KAWASAKI INSTITUTE OF INDUSTRIAL PROMOTION (JP) | 2026-05-07 | — | — | US | disclosed |
| US-11524073-B2 | Anti-human ADRB3 monoclonal antibody and application thereof in disease diagnosis and treatment | ZHENG MENG (CN) | 2022-12-13 | — | — | US | disclosed |
| US-20220387610-A1 | PEPTIDE-CONJUGATED PRODRUGS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2022-12-08 | — | — | US | disclosed |
| US-20220241203-A1 | METHOD FOR PRODUCTION OF LIPOSOMES | UNIVERSIDADE DO MINHO (PT) | 2022-08-04 | — | — | US | disclosed |
| US-20220168337-A1 | PRODUCING ATP AND IMPROVING MITOCHONDRIAL FUNCTION IN A MAMMAL USING A POLY-OXYGENATED METAL HYDROXIDE | HEMOTEK LLC (US) | 2022-06-02 | — | — | US | disclosed |
| CN-114134198-A | Reagent, device and method for rapidly counting eukaryotic microorganisms | 国家粮食和物资储备局科学研究院 | 2022-03-04 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12622975-B2 | Peptide-conjugated prodrugs | PEPD, PAM, VIP | MEN1 1217/4885MAPT 3330/4885HTT 3996/4885 |
| US-20220387610-A1 | PEPTIDE-CONJUGATED PRODRUGS | VIP, DNPEP, PEPD | MEN1 1147/4885MAPT 4191/4885HTT 4732/4885 |
| US-20260124140-A1 | NON-FOULING OR SUPER STEALTH VESICLE | FUCA2, LNPEP, EEA1 | MEN1 3433/4885MAPT 3587/4885HTT 3389/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.